Category: Bioworks
-
Ginkgo Bioworks executive sells over $1,900 in stock By Investing.com
•
According to the latest filings with the U.S. Securities and Exchange Commission, an executive at Ginkgo Bioworks Holdings, Inc. (NYSE: Ginkgo), a leading biotech company, recently conducted a stock transaction. Stephen P. Quinn, the company’s chief accounting officer, sold a total of 316 shares of Class A common stock on…